Quant Pick - Sun Pharmaceuticals: ICICI Direct

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

ICICI Direct's research report on Sun Pharmaceuticals

Recommendation

Buy Sun Pharmaceuticals in range of Rs 625-635 Target: Rs 738 Stop Loss: Rs 570 Time frame: Three months.

Derivatives & Quantitative Outlook

The pharma space has seen healthy consolidation in the last couple of months amid a broader market recovery. We believe the sector is set to resume its next round of upside move after a round of consolidation. As long positions are still intact in Sun Pharma, we believe the stock will resume its upward momentum in the near term. The open interest in the stock had moved to a five-month highs in early January 2021. Since then, it has seen a decline in OI at the end of February while OI levels have come down more than 8% along with a gradual fall in stock prices. Closure of leverage positions was seen in the stock in February indicating closure of long positions. We believe long positions in the stock are intact. Also, in the last couple of days the stock has witnessed long additions along with price rise. The upward bias may continue in it in coming weeks.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More